6-MethoxytricinCAS# 76015-42-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 76015-42-4 | SDF | Download SDF |
PubChem ID | 14034284 | Appearance | Powder |
Formula | C18H16O8 | M.Wt | 360.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | 4',5,7-Trihydroxy 3',5',6-trimethoxyflavone | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-6-methoxychromen-4-one | ||
SMILES | COC1=CC(=CC(=C1O)OC)C2=CC(=O)C3=C(O2)C=C(C(=C3O)OC)O | ||
Standard InChIKey | BVRHGBHZAQNORL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H16O8/c1-23-13-4-8(5-14(24-2)16(13)21)11-6-9(19)15-12(26-11)7-10(20)18(25-3)17(15)22/h4-7,20-22H,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
6-Methoxytricin Dilution Calculator
6-Methoxytricin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7755 mL | 13.8773 mL | 27.7546 mL | 55.5093 mL | 69.3866 mL |
5 mM | 0.5551 mL | 2.7755 mL | 5.5509 mL | 11.1019 mL | 13.8773 mL |
10 mM | 0.2775 mL | 1.3877 mL | 2.7755 mL | 5.5509 mL | 6.9387 mL |
50 mM | 0.0555 mL | 0.2775 mL | 0.5551 mL | 1.1102 mL | 1.3877 mL |
100 mM | 0.0278 mL | 0.1388 mL | 0.2775 mL | 0.5551 mL | 0.6939 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (+)-Lupanine hydrochloride
Catalog No.:BCN0333
CAS No.:1025-39-4
- Lavandulyl acetate
Catalog No.:BCN0332
CAS No.:25905-14-0
- Lavandulol
Catalog No.:BCN0331
CAS No.:58461-27-1
- Lactucin
Catalog No.:BCN0330
CAS No.:1891-29-8
- Isoxanthohumol
Catalog No.:BCN0329
CAS No.:521-48-2
- Isomenthone
Catalog No.:BCN0328
CAS No.:491-07-6
- Hyperforin (stable Dicyclohexylammonium salt)
Catalog No.:BCN0327
CAS No.:238074-03-8
- 3'-Hydroxyflavone
Catalog No.:BCN0326
CAS No.:70460-18-3
- (Rac)-Hesperetin
Catalog No.:BCN0325
CAS No.:69097-99-0
- Grindelic acid
Catalog No.:BCN0324
CAS No.:1438-57-9
- Fukinolic acid
Catalog No.:BCN0323
CAS No.:50982-40-6
- trans-Ferulic acid
Catalog No.:BCN0322
CAS No.:537-98-4
- 16-O-Methylcafestol
Catalog No.:BCN0335
CAS No.:108214-28-4
- Naringenin chalcone
Catalog No.:BCN0336
CAS No.:25515-46-2
- Pinocembroside
Catalog No.:BCN0337
CAS No.:75829-43-5
- (S)-4',5,7-Trihydroxy-6-prenylflavanone
Catalog No.:BCN0338
CAS No.:68682-01-9
- Sophoraflavanone B
Catalog No.:BCN0339
CAS No.:68682-02-0
- Rebaudioside I
Catalog No.:BCN0340
CAS No.:1220616-34-1
- Rebaudioside O
Catalog No.:BCN0341
CAS No.:1220616-48-7
- Sabinene
Catalog No.:BCN0342
CAS No.:3387-41-5
- (RS)-Sakuranetin
Catalog No.:BCN0343
CAS No.:520-29-6
- trans-Sinapic acid
Catalog No.:BCN0344
CAS No.:7362-37-0
- Solanthrene
Catalog No.:BCN0345
CAS No.:26516-51-8
- Cannabisin G
Catalog No.:BCN0346
CAS No.:
Inhibitory Effect of Chemical Constituents Isolated from Artemisia iwayomogi on Polyol Pathway and Simultaneous Quantification of Major Bioactive Compounds.[Pubmed:28512639]
Biomed Res Int. 2017;2017:7375615.
Blocking the polyol pathway plays an important role preventing diabetic complications. Therefore, aldose reductase (AR) and advanced glycation endproducts (AGEs) formation has significant effect on diabetic complications. Artemisia iwayomogi has long been used as treatment of various diseases in Korea. However, no literatures have reported on AR and AGEs formation inhibitory activities of A. iwayomogi. For these reasons, we aimed to assess that A. iwayomogi had potential as anti-diabetic complications agents. We led to isolation of two coumarins (1 and 2), nine flavonoids (3-11), five caffeoylquinic acids (12-16), three diterpene glycosides (17-19), and one phenolic compound (20) from A. iwayomogi. Among them, hispidulin (4), 6-Methoxytricin (6), arteanoflavone (7), quercetin-3-gentiobioside (10), 1,3-di-O-caffeoylquinic acid (13), and suavioside A (18) were first reported on the isolation from A. iwayomogi. Not only two coumarins (1 and 2), nine flavonoids (3-11), and five caffeoylquinic acids (12-16) but also extracts showed significant inhibitor on AR and AGEs formation activities. We analyzed contents of major bioactive compounds in Korea's various regions of A. iwayomogi. Overall, we selected Yangyang, Gangwon-do, from June, which contained the highest amounts of bioactive compounds, as suitable areas for cultivating A. iwayomogi as preventive or therapeutic agent in the treatment of diabetic complications.
Antiproliferative activity of Artemisia asiatica extract and its constituents on human tumor cell lines.[Pubmed:25295671]
Planta Med. 2014 Dec;80(18):1692-7.
The extract of Artemisia asiatica herb with antiproliferative activity against four human tumor cell lines (A2780, A431, HeLa, and MCF7) was analyzed by the MTT assay, and bioassay-directed fractionation was carried out in order to identify the compounds responsible for the cytotoxic activity. Guaianolide (1-4), seco-guianolide (5), germacranolide (6) and eudesmanolide sesquiterpenes (7), monoterpenes (8, 9), including the new compound artemisia alcohol glucoside (8), and flavonoids (10-16) were isolated as a result of a multistep chromatographic procedure (CC, CPC, PLC, and gel filtration). The compounds were identified by means of UV, MS, and NMR spectroscopy, including (1)H-and (13)C-NMR, (1)H-(1)H COSY, NOESY, HSQC, and HMBC experiments. The isolated compounds 1-16 were evaluated for their tumor cell growth-inhibitory activities on a panel of four adherent cancer cell lines, and different types of secondary metabolites were found to be responsible for the cytotoxic effects of the extract. Especially cirsilineol (13), 3beta-chloro-4alpha,10alpha-dihydroxy-1alpha,2alpha-epoxy-5alpha,7alphaH-guai-11( 13)-en-12,6alpha-olide (3), and iso-seco-tanapartholide 3-O-methyl ester (5) exerted marked cytotoxic effects against the investigated cell lines, while jaceosidin (12), 6-Methoxytricin (15), artecanin (2), and 5,7,4',5'-tetrahydroxy-6,3'-dimethoxyflavone (14) were moderately active. All the sesquiterpenes and monoterpenes are reported here for the first time from this species, and in the case of artecanin (2), 3alpha-chloro-4beta,10alpha-dihydroxy-1beta,2beta-epoxy-5alpha,7alphaH-guai-11(13 )-en-12,6alpha-olide (4), ridentin (6), and ridentin B (7), previously unreported NMR spectroscopic data were determined.
Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita.[Pubmed:18721870]
J Ethnopharmacol. 2008 Oct 30;120(1):1-6.
AIM OF THE STUDY: Artemisia vestita is a common traditional Tibetan medicinal plant which has been used widely in China for treating various inflammatory diseases. Since little is known about its active components, the purpose of this study was to isolate and identify the immunosuppressive compounds from Artemisia vestita. MATERIALS AND METHODS: A bioassay-guided isolation was performed with picryl chloride-induced contact hypersensitivity in mice. MTT assay and Flow cytometric analysis were used for determining Con A-induced lymphocyte proliferation and CD25 expression in T cells, respectively. RESULTS: The ethanol extract of the Artemisia vestita was found to possess significant inhibitory activity against the picryl chloride-induced contact hypersensitivity in mice. Then 4 fractions were isolated by macroporous adsorption resin and one of these fractions (AV3), which showed the highest activity in in vivo test, was further subjected to column chromatography. Nine known flavones were isolated and identified as pectolinarigenin (1), jaceosidin (2), cirsilineol (3), cirsimaritin (4), hispidulin (5), quercetin (6), 6-Methoxytricin (7), acacetin (8), and apigenin (9). The structures of the 9 flavones were elucidated by spectral techniques. All the compounds were evaluated for their inhibitory activity on the proliferation and activation of T cells in vitro. Among the 9 flavones, cirsilineol (3), 6-Methoxytricin (7) and apigenin (9) significantly inhibited T cell proliferation and activation in the bioassays. CONCLUSION: The result suggests that cirsilineol, 6-Methoxytricin and apigenin are the major active components in Artemisia vestita.